Literature DB >> 25844678

Intratubular germ cell neoplasia of the testis: a brief review.

Turki Al-Hussain1, Nasir Bakshi, Mohammed Akhtar.   

Abstract

Germ cell tumors of the testis may be divided into 3 broad categories according to age at presentation. The tumors in the pediatric age group include teratoma and yolk sac tumor. These tumors are generally not associated with convincing intratubular neoplasia. The second group consists of tumors presenting in third and fourth decade of life and include seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma as well as mixed germ cell tumors. The precursor cell for these tumors is an abnormal gonocyte that fails to differentiate completely into spermatogonia. These abnormal cells stay dormant in the gonad during intrauterine life as well as infancy and childhood, but undergo proliferation during puberty and can be identified as intratubular germ cell neoplasia unclassified (IGCNU). These tumor cells continue to manifest protein expression pattern that resembles primitive germ cells (PLAP, c-KIT, OCT3/4). After a variable interval following puberty, IGCNU cells may acquire ability to penetrate the seminiferous tubules and present as an overt germ cell tumor. Acquisition of isochrome 12 and other genetic abnormalities are usually associated with this transition. The level of DNA methylation generally determines the phenotype of the germ cell tumor. The third type of germ cell tumors is spermatocytic seminoma, which is a rare tumor encountered later in life usually in fifth and sixth decade. The cell of origin of this tumor is probably postpubertal mature spermatogonia which acquire abnormal proliferative capability probably due to gain of chromosome 9 resulting in activation and amplification of genes such as DMRT1. The tumor cells manifest many of the proteins normally expressed by mature sperms such as VASA, SSX2, and occasionally OCT2. Although spermatocytic seminoma may also have an intratubular growth phase, it completely lacks features of IGCNU.

Entities:  

Mesh:

Year:  2015        PMID: 25844678     DOI: 10.1097/PAP.0000000000000066

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  6 in total

Review 1.  Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  Lisal J Folsom; Mariam Hjaige; Jiayan Liu; Erica A Eugster; Richard J Auchus
Journal:  Mol Cell Endocrinol       Date:  2018-11-30       Impact factor: 4.102

2.  Proceedings of the 2017 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Famke Aeffner; Dinesh S Bangari; Torrie A Crabbs; Stacey Fossey; Shayne C Gad; Wanda M Haschek; Jessica S Hoane; Kyathanahalli Janardhan; Ramesh C Kovi; Gail Pearse; Lyn M Wancket; Erin M Quist
Journal:  Toxicol Pathol       Date:  2017-11-07       Impact factor: 1.902

Review 3.  Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure?

Authors:  Alice Faure; Aurore Bouty; Mike O'Brien; Jorgen Thorup; John Hutson; Yves Heloury
Journal:  Nat Rev Urol       Date:  2016-01-20       Impact factor: 14.432

4.  Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors.

Authors:  J Keith Killian; Lambert C J Dorssers; Britton Trabert; Ad J M Gillis; Michael B Cook; Yonghong Wang; Joshua J Waterfall; Holly Stevenson; William I Smith; Natalia Noyes; Parvathy Retnakumar; J Hans Stoop; J Wolter Oosterhuis; Paul S Meltzer; Katherine A McGlynn; Leendert H J Looijenga
Journal:  Genome Res       Date:  2016-10-20       Impact factor: 9.043

5.  Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ.

Authors:  Z Cierna; M Mego; I Jurisica; K Machalekova; M Chovanec; V Miskovska; D Svetlovska; K Kalavska; K Rejlekova; K Kajo; J Mardiak; P Babal
Journal:  BMC Cancer       Date:  2016-08-04       Impact factor: 4.430

Review 6.  Extremely Late Recurrence 21 Years after Total Removal of Immature Teratoma: A Case Report and Literature Review.

Authors:  Yui Mano; Masayuki Kanamori; Toshihiro Kumabe; Ryuta Saito; Mika Watanabe; Yukihiko Sonoda; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-12-07       Impact factor: 1.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.